nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—CYP1A2—Pentoxifylline—systemic scleroderma	0.0743	0.255	CbGbCtD
Iloperidone—CYP1A2—Leflunomide—systemic scleroderma	0.0709	0.243	CbGbCtD
Iloperidone—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0588	0.202	CbGbCtD
Iloperidone—CYP2D6—Captopril—systemic scleroderma	0.0458	0.157	CbGbCtD
Iloperidone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0229	0.0788	CbGbCtD
Iloperidone—HTR7—myenteric nerve plexus—systemic scleroderma	0.0205	0.15	CbGeAlD
Iloperidone—CYP3A4—Prednisone—systemic scleroderma	0.0183	0.063	CbGbCtD
Iloperidone—HTR7—pulmonary artery—systemic scleroderma	0.0145	0.106	CbGeAlD
Iloperidone—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0128	0.0935	CbGeAlD
Iloperidone—HTR2A—pulmonary artery—systemic scleroderma	0.00907	0.0662	CbGeAlD
Iloperidone—HTR1D—artery—systemic scleroderma	0.00677	0.0494	CbGeAlD
Iloperidone—HTR7—artery—systemic scleroderma	0.00539	0.0393	CbGeAlD
Iloperidone—HTR1D—blood vessel—systemic scleroderma	0.00527	0.0385	CbGeAlD
Iloperidone—HTR7—endothelium—systemic scleroderma	0.00455	0.0332	CbGeAlD
Iloperidone—HTR7—blood vessel—systemic scleroderma	0.0042	0.0306	CbGeAlD
Iloperidone—HTR2A—artery—systemic scleroderma	0.00336	0.0245	CbGeAlD
Iloperidone—HTR2A—endothelium—systemic scleroderma	0.00284	0.0207	CbGeAlD
Iloperidone—HTR1D—connective tissue—systemic scleroderma	0.0027	0.0197	CbGeAlD
Iloperidone—HTR2A—blood vessel—systemic scleroderma	0.00262	0.0191	CbGeAlD
Iloperidone—SIGMAR1—smooth muscle tissue—systemic scleroderma	0.00231	0.0168	CbGeAlD
Iloperidone—HTR7—connective tissue—systemic scleroderma	0.00215	0.0157	CbGeAlD
Iloperidone—HTR7—smooth muscle tissue—systemic scleroderma	0.00197	0.0144	CbGeAlD
Iloperidone—SIGMAR1—tendon—systemic scleroderma	0.00173	0.0126	CbGeAlD
Iloperidone—HRH1—connective tissue—systemic scleroderma	0.00161	0.0117	CbGeAlD
Iloperidone—ADRA2A—connective tissue—systemic scleroderma	0.00158	0.0115	CbGeAlD
Iloperidone—HTR7—digestive system—systemic scleroderma	0.00156	0.0113	CbGeAlD
Iloperidone—SIGMAR1—lung—systemic scleroderma	0.00152	0.0111	CbGeAlD
Iloperidone—HTR7—tendon—systemic scleroderma	0.00148	0.0108	CbGeAlD
Iloperidone—HRH1—smooth muscle tissue—systemic scleroderma	0.00147	0.0107	CbGeAlD
Iloperidone—ADRA2C—tendon—systemic scleroderma	0.00136	0.00993	CbGeAlD
Iloperidone—HTR2A—connective tissue—systemic scleroderma	0.00134	0.0098	CbGeAlD
Iloperidone—HTR7—lung—systemic scleroderma	0.0013	0.00948	CbGeAlD
Iloperidone—CYP1A2—digestive system—systemic scleroderma	0.00124	0.00905	CbGeAlD
Iloperidone—HTR2A—smooth muscle tissue—systemic scleroderma	0.00123	0.00896	CbGeAlD
Iloperidone—DRD2—lung—systemic scleroderma	0.00123	0.00896	CbGeAlD
Iloperidone—CYP3A5—digestive system—systemic scleroderma	0.0012	0.00873	CbGeAlD
Iloperidone—ADRA2C—lung—systemic scleroderma	0.00119	0.00871	CbGeAlD
Iloperidone—HRH1—digestive system—systemic scleroderma	0.00116	0.00847	CbGeAlD
Iloperidone—CYP2E1—digestive system—systemic scleroderma	0.00112	0.00814	CbGeAlD
Iloperidone—HRH1—tendon—systemic scleroderma	0.00111	0.00806	CbGeAlD
Iloperidone—ADRA2A—tendon—systemic scleroderma	0.00109	0.00792	CbGeAlD
Iloperidone—CYP2E1—tendon—systemic scleroderma	0.00106	0.00775	CbGeAlD
Iloperidone—CYP1A2—lung—systemic scleroderma	0.00104	0.00756	CbGeAlD
Iloperidone—CYP3A5—lung—systemic scleroderma	0.000999	0.00729	CbGeAlD
Iloperidone—HTR2A—digestive system—systemic scleroderma	0.00097	0.00708	CbGeAlD
Iloperidone—HRH1—lung—systemic scleroderma	0.00097	0.00708	CbGeAlD
Iloperidone—ADRA2A—lung—systemic scleroderma	0.000953	0.00695	CbGeAlD
Iloperidone—CYP2E1—lung—systemic scleroderma	0.000932	0.0068	CbGeAlD
Iloperidone—HTR2A—tendon—systemic scleroderma	0.000923	0.00674	CbGeAlD
Iloperidone—CYP3A4—digestive system—systemic scleroderma	0.000898	0.00655	CbGeAlD
Iloperidone—CYP2D6—digestive system—systemic scleroderma	0.000884	0.00645	CbGeAlD
Iloperidone—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000847	0.00148	CcSEcCtD
Iloperidone—Amnesia—Prednisone—systemic scleroderma	0.000847	0.00148	CcSEcCtD
Iloperidone—Increased appetite—Prednisone—systemic scleroderma	0.000847	0.00148	CcSEcCtD
Iloperidone—Arthralgia—Azathioprine—systemic scleroderma	0.000846	0.00148	CcSEcCtD
Iloperidone—Myalgia—Azathioprine—systemic scleroderma	0.000846	0.00148	CcSEcCtD
Iloperidone—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000844	0.00148	CcSEcCtD
Iloperidone—Vertigo—Leflunomide—systemic scleroderma	0.000844	0.00147	CcSEcCtD
Iloperidone—Angiopathy—Lisinopril—systemic scleroderma	0.000841	0.00147	CcSEcCtD
Iloperidone—Leukopenia—Leflunomide—systemic scleroderma	0.00084	0.00147	CcSEcCtD
Iloperidone—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000839	0.00147	CcSEcCtD
Iloperidone—Tremor—Mycophenolic acid—systemic scleroderma	0.000839	0.00147	CcSEcCtD
Iloperidone—Body temperature increased—Mometasone—systemic scleroderma	0.000837	0.00146	CcSEcCtD
Iloperidone—Mediastinal disorder—Lisinopril—systemic scleroderma	0.000835	0.00146	CcSEcCtD
Iloperidone—Paraesthesia—Captopril—systemic scleroderma	0.000835	0.00146	CcSEcCtD
Iloperidone—Palpitations—Leflunomide—systemic scleroderma	0.00083	0.00145	CcSEcCtD
Iloperidone—Dyspnoea—Captopril—systemic scleroderma	0.000829	0.00145	CcSEcCtD
Iloperidone—Mouth ulceration—Methotrexate—systemic scleroderma	0.000828	0.00145	CcSEcCtD
Iloperidone—Arrhythmia—Lisinopril—systemic scleroderma	0.000828	0.00145	CcSEcCtD
Iloperidone—Anaemia—Mycophenolic acid—systemic scleroderma	0.000828	0.00145	CcSEcCtD
Iloperidone—Somnolence—Captopril—systemic scleroderma	0.000827	0.00145	CcSEcCtD
Iloperidone—Agitation—Mycophenolic acid—systemic scleroderma	0.000823	0.00144	CcSEcCtD
Iloperidone—Gynaecomastia—Methotrexate—systemic scleroderma	0.00082	0.00143	CcSEcCtD
Iloperidone—Cardiac failure—Prednisone—systemic scleroderma	0.000815	0.00143	CcSEcCtD
Iloperidone—Mental disorder—Lisinopril—systemic scleroderma	0.000812	0.00142	CcSEcCtD
Iloperidone—Lethargy—Prednisone—systemic scleroderma	0.000812	0.00142	CcSEcCtD
Iloperidone—Dizziness—Pentoxifylline—systemic scleroderma	0.000811	0.00142	CcSEcCtD
Iloperidone—HTR2A—lung—systemic scleroderma	0.00081	0.00591	CbGeAlD
Iloperidone—Malnutrition—Lisinopril—systemic scleroderma	0.000807	0.00141	CcSEcCtD
Iloperidone—Infection—Azathioprine—systemic scleroderma	0.000806	0.00141	CcSEcCtD
Iloperidone—Vertigo—Mycophenolic acid—systemic scleroderma	0.000805	0.00141	CcSEcCtD
Iloperidone—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.000802	0.0014	CcSEcCtD
Iloperidone—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000802	0.0014	CcSEcCtD
Iloperidone—Fatigue—Captopril—systemic scleroderma	0.000802	0.0014	CcSEcCtD
Iloperidone—Arthralgia—Leflunomide—systemic scleroderma	0.000799	0.0014	CcSEcCtD
Iloperidone—Myalgia—Leflunomide—systemic scleroderma	0.000799	0.0014	CcSEcCtD
Iloperidone—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000798	0.0014	CcSEcCtD
Iloperidone—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.000796	0.00139	CcSEcCtD
Iloperidone—Palpitations—Mycophenolic acid—systemic scleroderma	0.000792	0.00138	CcSEcCtD
Iloperidone—Affect lability—Prednisone—systemic scleroderma	0.000783	0.00137	CcSEcCtD
Iloperidone—Dry mouth—Leflunomide—systemic scleroderma	0.000782	0.00137	CcSEcCtD
Iloperidone—Psychotic disorder—Prednisone—systemic scleroderma	0.000777	0.00136	CcSEcCtD
Iloperidone—Muscle spasms—Lisinopril—systemic scleroderma	0.000776	0.00136	CcSEcCtD
Iloperidone—Rash—Pentoxifylline—systemic scleroderma	0.000774	0.00135	CcSEcCtD
Iloperidone—Dermatitis—Pentoxifylline—systemic scleroderma	0.000773	0.00135	CcSEcCtD
Iloperidone—Feeling abnormal—Captopril—systemic scleroderma	0.000766	0.00134	CcSEcCtD
Iloperidone—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000763	0.00133	CcSEcCtD
Iloperidone—Myalgia—Mycophenolic acid—systemic scleroderma	0.000763	0.00133	CcSEcCtD
Iloperidone—Infection—Leflunomide—systemic scleroderma	0.000761	0.00133	CcSEcCtD
Iloperidone—Vision blurred—Lisinopril—systemic scleroderma	0.00076	0.00133	CcSEcCtD
Iloperidone—Asthenia—Mometasone—systemic scleroderma	0.00076	0.00133	CcSEcCtD
Iloperidone—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000759	0.00133	CcSEcCtD
Iloperidone—Hypotension—Azathioprine—systemic scleroderma	0.000758	0.00133	CcSEcCtD
Iloperidone—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000757	0.00132	CcSEcCtD
Iloperidone—Tremor—Lisinopril—systemic scleroderma	0.000756	0.00132	CcSEcCtD
Iloperidone—Mood swings—Prednisone—systemic scleroderma	0.000754	0.00132	CcSEcCtD
Iloperidone—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000754	0.00132	CcSEcCtD
Iloperidone—Nervous system disorder—Leflunomide—systemic scleroderma	0.000751	0.00131	CcSEcCtD
Iloperidone—Tachycardia—Leflunomide—systemic scleroderma	0.000748	0.00131	CcSEcCtD
Iloperidone—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000746	0.0013	CcSEcCtD
Iloperidone—Anaemia—Lisinopril—systemic scleroderma	0.000746	0.0013	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000739	0.00129	CcSEcCtD
Iloperidone—Confusional state—Mycophenolic acid—systemic scleroderma	0.000737	0.00129	CcSEcCtD
Iloperidone—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000737	0.00129	CcSEcCtD
Iloperidone—Body temperature increased—Captopril—systemic scleroderma	0.000735	0.00129	CcSEcCtD
Iloperidone—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000732	0.00128	CcSEcCtD
Iloperidone—Oedema—Mycophenolic acid—systemic scleroderma	0.000731	0.00128	CcSEcCtD
Iloperidone—Nausea—Pentoxifylline—systemic scleroderma	0.000729	0.00127	CcSEcCtD
Iloperidone—Infection—Mycophenolic acid—systemic scleroderma	0.000726	0.00127	CcSEcCtD
Iloperidone—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000725	0.00127	CcSEcCtD
Iloperidone—Vertigo—Lisinopril—systemic scleroderma	0.000725	0.00127	CcSEcCtD
Iloperidone—Diarrhoea—Mometasone—systemic scleroderma	0.000724	0.00127	CcSEcCtD
Iloperidone—Hypokalaemia—Prednisone—systemic scleroderma	0.000724	0.00127	CcSEcCtD
Iloperidone—Leukopenia—Lisinopril—systemic scleroderma	0.000722	0.00126	CcSEcCtD
Iloperidone—Renal failure acute—Methotrexate—systemic scleroderma	0.00072	0.00126	CcSEcCtD
Iloperidone—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000717	0.00125	CcSEcCtD
Iloperidone—Hypotension—Leflunomide—systemic scleroderma	0.000716	0.00125	CcSEcCtD
Iloperidone—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000713	0.00125	CcSEcCtD
Iloperidone—Palpitations—Lisinopril—systemic scleroderma	0.000713	0.00125	CcSEcCtD
Iloperidone—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000711	0.00124	CcSEcCtD
Iloperidone—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000707	0.00124	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000701	0.00122	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000698	0.00122	CcSEcCtD
Iloperidone—Paraesthesia—Leflunomide—systemic scleroderma	0.000688	0.0012	CcSEcCtD
Iloperidone—Arthralgia—Lisinopril—systemic scleroderma	0.000687	0.0012	CcSEcCtD
Iloperidone—Myalgia—Lisinopril—systemic scleroderma	0.000687	0.0012	CcSEcCtD
Iloperidone—Dyspnoea—Leflunomide—systemic scleroderma	0.000683	0.00119	CcSEcCtD
Iloperidone—Hypotension—Mycophenolic acid—systemic scleroderma	0.000683	0.00119	CcSEcCtD
Iloperidone—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00068	0.00119	CcSEcCtD
Iloperidone—Lethargy—Methotrexate—systemic scleroderma	0.000679	0.00119	CcSEcCtD
Iloperidone—Dry mouth—Lisinopril—systemic scleroderma	0.000672	0.00117	CcSEcCtD
Iloperidone—Feeling abnormal—Azathioprine—systemic scleroderma	0.000669	0.00117	CcSEcCtD
Iloperidone—Rash—Mometasone—systemic scleroderma	0.000667	0.00117	CcSEcCtD
Iloperidone—Asthenia—Captopril—systemic scleroderma	0.000667	0.00117	CcSEcCtD
Iloperidone—Dermatitis—Mometasone—systemic scleroderma	0.000667	0.00117	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000666	0.00116	CcSEcCtD
Iloperidone—Confusional state—Lisinopril—systemic scleroderma	0.000664	0.00116	CcSEcCtD
Iloperidone—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000662	0.00116	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000662	0.00116	CcSEcCtD
Iloperidone—Fatigue—Leflunomide—systemic scleroderma	0.000661	0.00116	CcSEcCtD
Iloperidone—Oedema—Lisinopril—systemic scleroderma	0.000658	0.00115	CcSEcCtD
Iloperidone—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000656	0.00115	CcSEcCtD
Iloperidone—Infection—Lisinopril—systemic scleroderma	0.000654	0.00114	CcSEcCtD
Iloperidone—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000653	0.00114	CcSEcCtD
Iloperidone—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000652	0.00114	CcSEcCtD
Iloperidone—Somnolence—Mycophenolic acid—systemic scleroderma	0.00065	0.00114	CcSEcCtD
Iloperidone—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00065	0.00114	CcSEcCtD
Iloperidone—Tachycardia—Lisinopril—systemic scleroderma	0.000643	0.00112	CcSEcCtD
Iloperidone—Body temperature increased—Azathioprine—systemic scleroderma	0.000641	0.00112	CcSEcCtD
Iloperidone—Diarrhoea—Captopril—systemic scleroderma	0.000636	0.00111	CcSEcCtD
Iloperidone—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000635	0.00111	CcSEcCtD
Iloperidone—Erectile dysfunction—Prednisone—systemic scleroderma	0.000633	0.00111	CcSEcCtD
Iloperidone—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000633	0.00111	CcSEcCtD
Iloperidone—Feeling abnormal—Leflunomide—systemic scleroderma	0.000631	0.0011	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000631	0.0011	CcSEcCtD
Iloperidone—Fatigue—Mycophenolic acid—systemic scleroderma	0.00063	0.0011	CcSEcCtD
Iloperidone—Mood swings—Methotrexate—systemic scleroderma	0.00063	0.0011	CcSEcCtD
Iloperidone—Nausea—Mometasone—systemic scleroderma	0.000629	0.0011	CcSEcCtD
Iloperidone—Weight increased—Prednisone—systemic scleroderma	0.000626	0.00109	CcSEcCtD
Iloperidone—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000625	0.00109	CcSEcCtD
Iloperidone—Weight decreased—Prednisone—systemic scleroderma	0.000622	0.00109	CcSEcCtD
Iloperidone—Hypotension—Lisinopril—systemic scleroderma	0.000615	0.00108	CcSEcCtD
Iloperidone—Dizziness—Captopril—systemic scleroderma	0.000615	0.00108	CcSEcCtD
Iloperidone—Body temperature increased—Leflunomide—systemic scleroderma	0.000606	0.00106	CcSEcCtD
Iloperidone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000602	0.00105	CcSEcCtD
Iloperidone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000602	0.00105	CcSEcCtD
Iloperidone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000602	0.00105	CcSEcCtD
Iloperidone—Breast disorder—Methotrexate—systemic scleroderma	0.000601	0.00105	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.0006	0.00105	CcSEcCtD
Iloperidone—Paraesthesia—Lisinopril—systemic scleroderma	0.000591	0.00103	CcSEcCtD
Iloperidone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000589	0.00103	CcSEcCtD
Iloperidone—Dyspnoea—Lisinopril—systemic scleroderma	0.000587	0.00103	CcSEcCtD
Iloperidone—Rash—Captopril—systemic scleroderma	0.000586	0.00103	CcSEcCtD
Iloperidone—Dermatitis—Captopril—systemic scleroderma	0.000586	0.00102	CcSEcCtD
Iloperidone—Somnolence—Lisinopril—systemic scleroderma	0.000585	0.00102	CcSEcCtD
Iloperidone—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000582	0.00102	CcSEcCtD
Iloperidone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000578	0.00101	CcSEcCtD
Iloperidone—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000577	0.00101	CcSEcCtD
Iloperidone—Asthma—Methotrexate—systemic scleroderma	0.000575	0.001	CcSEcCtD
Iloperidone—Infection—Mycophenolate mofetil—systemic scleroderma	0.000573	0.001	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000568	0.000994	CcSEcCtD
Iloperidone—Fatigue—Lisinopril—systemic scleroderma	0.000568	0.000993	CcSEcCtD
Iloperidone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000566	0.000989	CcSEcCtD
Iloperidone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000563	0.000984	CcSEcCtD
Iloperidone—Diarrhoea—Azathioprine—systemic scleroderma	0.000555	0.000971	CcSEcCtD
Iloperidone—Nausea—Captopril—systemic scleroderma	0.000552	0.000966	CcSEcCtD
Iloperidone—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000551	0.000963	CcSEcCtD
Iloperidone—Asthenia—Leflunomide—systemic scleroderma	0.00055	0.000961	CcSEcCtD
Iloperidone—Feeling abnormal—Lisinopril—systemic scleroderma	0.000543	0.000949	CcSEcCtD
Iloperidone—Connective tissue disorder—Prednisone—systemic scleroderma	0.000541	0.000946	CcSEcCtD
Iloperidone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000539	0.000943	CcSEcCtD
Iloperidone—Dysuria—Methotrexate—systemic scleroderma	0.000537	0.00094	CcSEcCtD
Iloperidone—Dizziness—Azathioprine—systemic scleroderma	0.000537	0.000938	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000534	0.000934	CcSEcCtD
Iloperidone—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000529	0.000925	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000526	0.000919	CcSEcCtD
Iloperidone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000524	0.000917	CcSEcCtD
Iloperidone—Diarrhoea—Leflunomide—systemic scleroderma	0.000524	0.000917	CcSEcCtD
Iloperidone—Body temperature increased—Lisinopril—systemic scleroderma	0.000521	0.00091	CcSEcCtD
Iloperidone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000518	0.000906	CcSEcCtD
Iloperidone—Eye disorder—Prednisone—systemic scleroderma	0.000514	0.000899	CcSEcCtD
Iloperidone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000514	0.000899	CcSEcCtD
Iloperidone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000513	0.000897	CcSEcCtD
Iloperidone—Rash—Azathioprine—systemic scleroderma	0.000512	0.000895	CcSEcCtD
Iloperidone—Dermatitis—Azathioprine—systemic scleroderma	0.000511	0.000894	CcSEcCtD
Iloperidone—Dizziness—Leflunomide—systemic scleroderma	0.000507	0.000886	CcSEcCtD
Iloperidone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.0005	0.000875	CcSEcCtD
Iloperidone—Stomatitis—Methotrexate—systemic scleroderma	0.000499	0.000873	CcSEcCtD
Iloperidone—Angiopathy—Prednisone—systemic scleroderma	0.000499	0.000873	CcSEcCtD
Iloperidone—Conjunctivitis—Methotrexate—systemic scleroderma	0.000498	0.000871	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000498	0.000871	CcSEcCtD
Iloperidone—Arrhythmia—Prednisone—systemic scleroderma	0.000492	0.00086	CcSEcCtD
Iloperidone—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000485	0.000847	CcSEcCtD
Iloperidone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000483	0.000845	CcSEcCtD
Iloperidone—Epistaxis—Methotrexate—systemic scleroderma	0.000483	0.000845	CcSEcCtD
Iloperidone—Rash—Leflunomide—systemic scleroderma	0.000483	0.000845	CcSEcCtD
Iloperidone—Dermatitis—Leflunomide—systemic scleroderma	0.000483	0.000844	CcSEcCtD
Iloperidone—Mental disorder—Prednisone—systemic scleroderma	0.000482	0.000843	CcSEcCtD
Iloperidone—Nausea—Azathioprine—systemic scleroderma	0.000482	0.000843	CcSEcCtD
Iloperidone—Malnutrition—Prednisone—systemic scleroderma	0.000479	0.000838	CcSEcCtD
Iloperidone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000475	0.000831	CcSEcCtD
Iloperidone—Asthenia—Lisinopril—systemic scleroderma	0.000472	0.000826	CcSEcCtD
Iloperidone—Rash—Mycophenolic acid—systemic scleroderma	0.000461	0.000806	CcSEcCtD
Iloperidone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000461	0.000805	CcSEcCtD
Iloperidone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000456	0.000797	CcSEcCtD
Iloperidone—Nausea—Leflunomide—systemic scleroderma	0.000455	0.000796	CcSEcCtD
Iloperidone—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000454	0.000794	CcSEcCtD
Iloperidone—Vision blurred—Prednisone—systemic scleroderma	0.000452	0.00079	CcSEcCtD
Iloperidone—Urethral disorder—Methotrexate—systemic scleroderma	0.000451	0.000788	CcSEcCtD
Iloperidone—Diarrhoea—Lisinopril—systemic scleroderma	0.000451	0.000788	CcSEcCtD
Iloperidone—Anaemia—Prednisone—systemic scleroderma	0.000443	0.000774	CcSEcCtD
Iloperidone—Agitation—Prednisone—systemic scleroderma	0.00044	0.00077	CcSEcCtD
Iloperidone—Dizziness—Lisinopril—systemic scleroderma	0.000435	0.000761	CcSEcCtD
Iloperidone—Nausea—Mycophenolic acid—systemic scleroderma	0.000434	0.000759	CcSEcCtD
Iloperidone—Vertigo—Prednisone—systemic scleroderma	0.00043	0.000753	CcSEcCtD
Iloperidone—Eye disorder—Methotrexate—systemic scleroderma	0.00043	0.000752	CcSEcCtD
Iloperidone—Tinnitus—Methotrexate—systemic scleroderma	0.000429	0.00075	CcSEcCtD
Iloperidone—Cardiac disorder—Methotrexate—systemic scleroderma	0.000427	0.000746	CcSEcCtD
Iloperidone—Angiopathy—Methotrexate—systemic scleroderma	0.000417	0.00073	CcSEcCtD
Iloperidone—Rash—Lisinopril—systemic scleroderma	0.000415	0.000726	CcSEcCtD
Iloperidone—Dermatitis—Lisinopril—systemic scleroderma	0.000415	0.000725	CcSEcCtD
Iloperidone—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000415	0.000725	CcSEcCtD
Iloperidone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000414	0.000724	CcSEcCtD
Iloperidone—Arthralgia—Prednisone—systemic scleroderma	0.000408	0.000713	CcSEcCtD
Iloperidone—Myalgia—Prednisone—systemic scleroderma	0.000408	0.000713	CcSEcCtD
Iloperidone—Mental disorder—Methotrexate—systemic scleroderma	0.000403	0.000705	CcSEcCtD
Iloperidone—Malnutrition—Methotrexate—systemic scleroderma	0.0004	0.0007	CcSEcCtD
Iloperidone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000395	0.00069	CcSEcCtD
Iloperidone—Nausea—Lisinopril—systemic scleroderma	0.000391	0.000684	CcSEcCtD
Iloperidone—Oedema—Prednisone—systemic scleroderma	0.000391	0.000684	CcSEcCtD
Iloperidone—Infection—Prednisone—systemic scleroderma	0.000389	0.000679	CcSEcCtD
Iloperidone—Nervous system disorder—Prednisone—systemic scleroderma	0.000384	0.000671	CcSEcCtD
Iloperidone—Tachycardia—Prednisone—systemic scleroderma	0.000382	0.000667	CcSEcCtD
Iloperidone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000382	0.000667	CcSEcCtD
Iloperidone—Vision blurred—Methotrexate—systemic scleroderma	0.000377	0.00066	CcSEcCtD
Iloperidone—Anaemia—Methotrexate—systemic scleroderma	0.00037	0.000647	CcSEcCtD
Iloperidone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000364	0.000636	CcSEcCtD
Iloperidone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000363	0.000635	CcSEcCtD
Iloperidone—Vertigo—Methotrexate—systemic scleroderma	0.00036	0.000629	CcSEcCtD
Iloperidone—Leukopenia—Methotrexate—systemic scleroderma	0.000358	0.000627	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000356	0.000623	CcSEcCtD
Iloperidone—Paraesthesia—Prednisone—systemic scleroderma	0.000351	0.000614	CcSEcCtD
Iloperidone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000343	0.000599	CcSEcCtD
Iloperidone—Myalgia—Methotrexate—systemic scleroderma	0.000341	0.000596	CcSEcCtD
Iloperidone—Arthralgia—Methotrexate—systemic scleroderma	0.000341	0.000596	CcSEcCtD
Iloperidone—Fatigue—Prednisone—systemic scleroderma	0.000337	0.00059	CcSEcCtD
Iloperidone—Confusional state—Methotrexate—systemic scleroderma	0.00033	0.000576	CcSEcCtD
Iloperidone—Infection—Methotrexate—systemic scleroderma	0.000325	0.000568	CcSEcCtD
Iloperidone—Feeling abnormal—Prednisone—systemic scleroderma	0.000322	0.000563	CcSEcCtD
Iloperidone—Nervous system disorder—Methotrexate—systemic scleroderma	0.000321	0.00056	CcSEcCtD
Iloperidone—Body temperature increased—Prednisone—systemic scleroderma	0.000309	0.000541	CcSEcCtD
Iloperidone—Hypotension—Methotrexate—systemic scleroderma	0.000305	0.000534	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000298	0.000521	CcSEcCtD
Iloperidone—Paraesthesia—Methotrexate—systemic scleroderma	0.000293	0.000513	CcSEcCtD
Iloperidone—Dyspnoea—Methotrexate—systemic scleroderma	0.000291	0.000509	CcSEcCtD
Iloperidone—Somnolence—Methotrexate—systemic scleroderma	0.000291	0.000508	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000282	0.000493	CcSEcCtD
Iloperidone—Fatigue—Methotrexate—systemic scleroderma	0.000282	0.000493	CcSEcCtD
Iloperidone—Asthenia—Prednisone—systemic scleroderma	0.000281	0.000491	CcSEcCtD
Iloperidone—Feeling abnormal—Methotrexate—systemic scleroderma	0.000269	0.000471	CcSEcCtD
Iloperidone—Diarrhoea—Prednisone—systemic scleroderma	0.000268	0.000468	CcSEcCtD
Iloperidone—Dizziness—Prednisone—systemic scleroderma	0.000259	0.000452	CcSEcCtD
Iloperidone—Body temperature increased—Methotrexate—systemic scleroderma	0.000258	0.000452	CcSEcCtD
Iloperidone—Rash—Prednisone—systemic scleroderma	0.000247	0.000431	CcSEcCtD
Iloperidone—Dermatitis—Prednisone—systemic scleroderma	0.000246	0.000431	CcSEcCtD
Iloperidone—Asthenia—Methotrexate—systemic scleroderma	0.000234	0.00041	CcSEcCtD
Iloperidone—Nausea—Prednisone—systemic scleroderma	0.000232	0.000406	CcSEcCtD
Iloperidone—Diarrhoea—Methotrexate—systemic scleroderma	0.000224	0.000391	CcSEcCtD
Iloperidone—Dizziness—Methotrexate—systemic scleroderma	0.000216	0.000378	CcSEcCtD
Iloperidone—Rash—Methotrexate—systemic scleroderma	0.000206	0.00036	CcSEcCtD
Iloperidone—Dermatitis—Methotrexate—systemic scleroderma	0.000206	0.00036	CcSEcCtD
Iloperidone—Nausea—Methotrexate—systemic scleroderma	0.000194	0.000339	CcSEcCtD
